Paying research subjects: participants' perspectives

M L Russell, D G Moralejo, E D Burgess, M L Russell, D G Moralejo, E D Burgess

Abstract

Objective: To explore the opinions of unpaid healthy volunteers on the payment of research subjects.

Design: Prospective cohort.

Setting: Southern Alberta, Canada.

Participants: Medically eligible persons responding to recruiting advertisements for a randomised vaccine trial were invited to take part in a study of informed consent at the point at which they formally consented or refused trial participation. Of 72 invited, 67 (62 trial consenters, 5 trial refusers) returned questionnaires at baseline and 54 at follow-up.

Outcome measures: Proportions of persons who agreed or disagreed with three close-ended statements on the payment of research subjects; themes and categories identified by content analysis of responses to an open-ended question.

Results: A minority (43.3%) agreed with paying either patient or healthy volunteer participants. Opinions did not change over time. Participants' comments addressed: benefits and drawbacks to research participation; benefits and drawbacks to paying research participants; conditions under which payment of research subjects would be acceptable, and the nature of acceptable recognition. Acceptable conditions were to improve problematic recruitment, to reimburse costs, and to recognise participants, particularly for their time investment. Both non-monetary and monetary recognition of volunteers were thought to be appropriate.

Conclusions: Most unpaid volunteers disagreed with paying research participants. The themes arising from their comments are similar to those that have been raised by ethicists and suggest that recognising the time and effort of participants should receive greater emphasis than presently occurs.

References

    1. Br J Clin Pharmacol. 1991 Aug;32(2):141-2
    1. Eur J Clin Pharmacol. 1993;45(1):15-21
    1. Nurs Res. 1994 Jul-Aug;43(4):253-5
    1. Ann Allergy Asthma Immunol. 1996 Apr;76(4):348-54
    1. Eur J Clin Pharmacol. 1990;38(5):443-6
    1. Clin Pharmacol Ther. 1977 May;21(5):515-9
    1. Bioethics. 1995 Jul;9(3-4):259-68
    1. Aviat Space Environ Med. 1982 Oct;53(10):1017-20
    1. Lancet. 1985 Jan 12;1(8420):93-4
    1. J Am Board Fam Pract. 1996 Jan-Feb;9(1):14-22

Source: PubMed

Подписаться